A single-dose mass balance and metabolite-profiling study of vemurafenib in patients with metastatic melanoma.
Goldinger SM, Rinderknecht J, Dummer R, Kuhn FP, Yang KH, Lee L, Ayala RC, Racha J, Geng W, Moore D, Liu M, Joe AK, Bazan SP, Grippo JF.
Goldinger SM, et al. Among authors: rinderknecht j.
Pharmacol Res Perspect. 2015 Mar;3(2):e00113. doi: 10.1002/prp2.113.
Pharmacol Res Perspect. 2015.
PMID: 25729580
Free PMC article.